Macrophage Inflammatory Response to Self‐Assembling Rosette Nanotubes
Source abstract
Abstract
Abstract Rosette nanotubes (RNTs) are a new class of nanomaterials with significant therapeutic potential. However, societal concerns related to the potential adverse health effects of engineered nanomaterials drew attention towards the investigation of their interaction with the human U937 macrophage cell line. The cells are treated with medium only (control), lysine (50 µg mL−1), lysine‐functionalized RNTs (RNT‐K; 1, 5, and 50 µg mL−1), Min‐U‐Sil quartz microparticles (80 µg mL−1), or lipopolysaccharide (1 µg mL−1). The supernatant and cells are assayed for cell viability, cytokine protein, and mRNA expression at 1, 6, and 24 h post‐treatment. The results indicate that RNT‐K activate transcription of proinflammatory genes (interleukin‐8 and tumor necrosis factor‐α (TNF‐α)) within 1 h, but this effect is not accompanied by protein secretion into the supernatant. The effect of the length of RNTs on human U937 macrophage viability is also investigated. Although both short and long RNT‐K exhibit time‐dependent effects on TNF‐α transcription, only the short RNT‐K (5 µg mL−1) increase TNF‐α concentration at 6 h relative to the long RNT‐K. Moreover, RNT‐K (1 and 5 µg mL−1) have no effect on cell viability by 24 h. These data indicate that RNT‐K do not induce a robust inflammatory response or cytotoxicity in the U937 human macrophage cell line, and therefore could be used for biomedical applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. 10.1289/ehp.733910.1289/ehp.7339 ↗
2. 10.1080/1743539070131476110.1080/17435390701314761 ↗
3. 10.1080/1743539070131472010.1080/17435390701314720 ↗
4. International Commission on Radiological Protection (ICRP) · 1994
5. 10.1038/sj.bjp.070713010.1038/sj.bjp.0707130 ↗
6. 10.1007/BF0302287310.1007/BF03022873 ↗
7. 10.1016/j.addr.2006.09.01010.1016/j.addr.2006.09.010 ↗
8. 10.1016/j.ejphar.2005.12.06810.1016/j.ejphar.2005.12.068 ↗
9. Bergamaschi E. · Int. J. Immunopathol. Pharmacol. · 2006 · 19 · 3
10. 10.1289/ehp.92971710.1289/ehp.929717 ↗
11. Duffield J. S. · Clin. Sci. · 2003 · 104 · 2710.1042/cs1040027 ↗
12. 10.1016/j.toxlet.2005.08.01110.1016/j.toxlet.2005.08.011 ↗
13. 10.1021/nl048958610.1021/nl0489586 ↗
14. 10.1002/jbm.a.3057710.1002/jbm.a.30577 ↗
15. 10.1021/nl061160x10.1021/nl061160x ↗
16. 10.1021/ja005886l10.1021/ja005886l ↗
17. 10.1021/ja026164s10.1021/ja026164s ↗
18. 10.1073/pnas.03252709910.1073/pnas.032527099 ↗
19. Journeay W. S. · Int. J. Nanomed. · 2008 · 3 · 373
20. 10.1002/smll.20070070010.1002/smll.200700700 ↗
21. 10.1089/jam.2000.13.36910.1089/jam.2000.13.369 ↗
22. 10.3109/0190214850905752210.3109/01902148509057522 ↗
23. 10.1165/ajrcmb/8.3.31110.1165/ajrcmb/8.3.311 ↗
24. 10.1183/09059180.05.0000950210.1183/09059180.05.00009502 ↗
25. Oberdorster G. · Environ. Health Perspect. · 1994 · 102 · 173
26. 10.1021/es048729l10.1021/es048729l ↗
27. 10.1016/j.toxlet.2006.02.00110.1016/j.toxlet.2006.02.001 ↗
28. 10.1016/j.toxlet.2006.11.00110.1016/j.toxlet.2006.11.001 ↗
29. 10.1289/ehp.809410.1289/ehp.8094 ↗
30. McAteer J. A. · 2002
31. 10.1164/ajrccm/139.4.101010.1164/ajrccm/139.4.1010 ↗
32. 10.1016/S0378-4274(99)00282-910.1016/S0378-4274(99)00282-9 ↗
33. Driscoll K. E. · Environ. Health Perspect. · 1997 · 105 · 1159
34. 10.1007/s00011-006-6162-310.1007/s00011-006-6162-3 ↗
35. 10.1016/S0021-9258(17)31505-310.1016/S0021-9258(17)31505-3 ↗
36. 10.1016/S0021-9258(19)88692-110.1016/S0021-9258(19)88692-1 ↗
37. 10.1016/S1359-6101(03)00059-510.1016/S1359-6101(03)00059-5 ↗
38. 10.1615/CritRevImmunol.v26.i4.2010.1615/CritRevImmunol.v26.i4.20 ↗
39. 10.1289/ehp.849710.1289/ehp.8497 ↗
40. 10.1080/08958379919725810.1080/089583799197258 ↗
41. 10.1186/1465-9921-6-8710.1186/1465-9921-6-87 ↗
42. 10.1039/b502429c10.1039/b502429c ↗
43. 10.1080/0895837060074777010.1080/08958370600747770 ↗
44. Lucarelli M. · Eur. Cytokine Netw. · 2004 · 15 · 339
45. 10.1002/ijc.291017050410.1002/ijc.2910170504 ↗